Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness
- 1 September 1992
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 340 (8820), 652-655
- https://doi.org/10.1016/0140-6736(92)92180-n
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Impact of Human Immunodeficiency Virus Infection on the Epidemiology and Treatment of Trypanosoma Brucei Gambiense Sleeping Sickness in Nioki, ZaireThe American Journal of Tropical Medicine and Hygiene, 1992
- New drug for trypanosomiasisThe Lancet, 1991
- Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesienseAntimicrobial Agents and Chemotherapy, 1990
- TRIAL OF PREDNISOLONE FOR PREVENTION OF MELARSOPROL-INDUCED ENCEPHALOPATHY IN GAMBIENSE SLEEPING SICKNESSThe Lancet, 1989
- DIFLUOROMETHYLORNITHINE FOR ARSENO-RESISTANT TRYPANOSOMA BRUCEI GAMBIENSE SLEEPING SICKNESSThe Lancet, 1987
- Treatment of Human Late Stage Gambiense Trypanosomiasis with α-Difluoromethylornithine (Eflornithine): Efficacy and Tolerance in 14 Cases in Côte D'IvoireThe American Journal of Tropical Medicine and Hygiene, 1987
- Difluoromethylornithine, an effective new treatment of gambian trypanosomiasisAmerican Journal Of Medicine, 1987
- Effects of the Ornithine Decarboxylase Inhibitors Dl-α-Difluoromethylornithine and α-Monofluoromethyldehydroornithine Methyl Ester Alone and in Combination with Suramin against Trypanosoma brucei brucei Central Nervous System ModelsThe American Journal of Tropical Medicine and Hygiene, 1987
- New Drug Combination for Experimental Late-Stage African Trypanosomiasis: DL-α-Difluoromethylornithine (DFMO) with Suramin *The American Journal of Tropical Medicine and Hygiene, 1984
- Kinetics of α-difluoromethylornithine: An irreversible inhibitor of ornithine decarboxylaseClinical Pharmacology & Therapeutics, 1981